Court of Appeal backs Astellas in UK patent fight over prostate cancer drug | Generics’ challenge fails as judges warn on ...

27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...

$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues. Already ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for ...

29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical ...

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its ...

Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...